Streetbeat News

Price Targets

NTRA

Goldman Sachs analyst Matthew Sykes has reaffirmed a Buy rating on Natera (NASDAQ:NTRA) and increased the price target from $64 to $80.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 3:34 pm

MYGN

Goldman Sachs analyst Matthew Sykes has reaffirmed a Buy rating on Myriad Genetics (NASDAQ:MYGN) and increased the price target from $28 to $31.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 3:33 pm

KLAC

Goldman Sachs analyst Toshiya Hari has reaffirmed a Buy rating on KLA Corporation (NASDAQ:KLAC) and increased the price target from $560 to $640.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 3:32 pm

INTC

Goldman Sachs analyst Toshiya Hari has maintained a Sell rating on Intel Corporation (NASDAQ:INTC) but increased the price target from $34 to $39.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 3:32 pm

HUM

Goldman Sachs analyst Nathan Rich has maintained a Buy rating on Humana (NYSE:HUM) but has reduced the price target from $515 to $450.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 3:31 pm

BKU

Wedbush analyst David Chiaverini has maintained a Neutral rating on BankUnited (NYSE:BKU) but has lowered the price target from $34 to $31.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 3:30 pm

GH

Goldman Sachs analyst Matthew Sykes has maintained a Buy rating on Guardant Health (NASDAQ:GH) but has reduced the price target from $43 to $37.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 3:29 pm

GNTX

Goldman Sachs analyst Mark Delaney has maintained a Neutral rating on Gentex (NASDAQ:GNTX) and increased the price target from $31 to $35.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 3:28 pm

CELH

Wedbush analyst Gerald Pascarelli has reiterated an Outperform rating on Celsius Holdings (NASDAQ:CELH) and maintained a price target of $75.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 3:27 pm

BAH

Goldman Sachs analyst Gavin Parsons has reaffirmed a Buy rating on Booz Allen Hamilton (NYSE:BAH) and increased the price target from $141 to $158.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 3:25 pm